W58P052220002
Cooperative Agreement
Overview
Grant Description
Covid-19 action. Industrial base expansion (IBX) of capacity for the manufacture of lipids used in lipid nano particle (LNP) technology for Covid-19 vaccines.
Awardee
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Plainsboro,
New Jersey
085362086
United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the End Date has been shortened from 06/05/32 to 08/17/23 and the total obligations have decreased 86% from $75,000,000 to $10,332,628.
Croda was awarded
IBX : Expanding Lipid Manufacturing Covid-19 Vaccine Technology
Cooperative Agreement W58P052220002
worth $10,332,628
from Joint PEO for Chemical, Biological, Radiological and Nuclear Defense in June 2022 with work to be completed primarily in Plainsboro New Jersey United States.
The grant
has a duration of 1 year 2 months and
was awarded through assistance program 12.360 Research on Chemical and Biological Defense.
Status
(Complete)
Last Modified 8/24/23
Period of Performance
6/6/22
Start Date
8/17/23
End Date
Funding Split
$10.3M
Federal Obligation
$0.0
Non-Federal Obligation
$10.3M
Total Obligated
Activity Timeline
Transaction History
Modifications to W58P052220002
Additional Detail
Award ID FAIN
W58P052220002
SAI Number
None
Award ID URI
None
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Other
Other
Awarding Office
W58P05 W6QK ACC-APG NATICK
Funding Office
W56XNH W6DZ JPMO CBD JPMO MCS (06)
Awardee UEI
J2W2CHMZLHZ2
Awardee CAGE
7ZGL3
Performance District
NJ-12
Senators
Robert Menendez
Cory Booker
Cory Booker
Modified: 8/24/23